KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Operating Leases (2019 - 2025)

Guardant Health's Operating Leases history spans 7 years, with the latest figure at $206.1 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 25.47% year-over-year to $206.1 million; the TTM value through Dec 2025 reached $206.1 million, up 25.47%, while the annual FY2025 figure was $206.1 million, 25.47% up from the prior year.
  • Operating Leases for Q4 2025 was $206.1 million at Guardant Health, up from $185.4 million in the prior quarter.
  • Across five years, Operating Leases topped out at $240.8 million in Q2 2022 and bottomed at $160.4 million in Q1 2025.
  • The 5-year median for Operating Leases is $208.4 million (2022), against an average of $201.2 million.
  • The largest annual shift saw Operating Leases soared 522.52% in 2021 before it decreased 22.76% in 2024.
  • A 5-year view of Operating Leases shows it stood at $226.1 million in 2021, then decreased by 7.09% to $210.0 million in 2022, then dropped by 11.51% to $185.8 million in 2023, then decreased by 11.6% to $164.3 million in 2024, then rose by 25.47% to $206.1 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Operating Leases are $206.1 million (Q4 2025), $185.4 million (Q3 2025), and $160.4 million (Q1 2025).